RICHNER-HANHART SYNDROME (TYROSINEMIA TYPE-II) - CASE-REPORT AND LITERATURE-REVIEW

被引:25
作者
ALHEMIDAN, AI
ALHAZZAA, SAF
机构
[1] Department of Ophthalmology, King Faisal Specialist Hospital and Research Centre, Riyadh
来源
OPHTHALMIC GENETICS | 1995年 / 16卷 / 01期
关键词
AMINO ACID; KERATITIS; HYPERKERATOSIS; MENTAL RETARDATION; RICHNER-HANHART SYNDROME; TYROSINEMIA TYPE-II; REVIEW;
D O I
10.3109/13816819509057850
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Richner-Hanhart syndrome (Tyrosinemia Type II) is an autosomal recessive disorder of amino acid metabolism characterized by ocular changes, painful palmoplantar hyperkeratosis, and mental retardation. Serum tyrosine increases due to tyrosine aminotransferase deficiency resulting in the deposition of tyrosine crystals in the cornea and in corneal inflammation. Patients are often misdiagnosed as having herpes simplex keratitis. We report on a child who presented with bilateral keratitis secondary to Tyrosinemia Type II diagnosed as herpes simplex keratitis.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 22 条
  • [1] Spanlang H., Beitrage Zur Klinik und Pathologic Seltener Horn hauter Krankungen, Z Augenheilkd, 62, pp. 21-71, (1927)
  • [2] Fuhs H., Uber das Switene syndrome Bon congenitalen Keratosen der Haut und cornea, Dermatol Z, 53, pp. 199-208, (1928)
  • [3] Richner H., Hornhautaffrektion bei keratoma palmare et plantare heriditarium, Klin Monatsbl Augenheilkd, 100, pp. 580-588, (1938)
  • [4] Hanhart E., Neue Sanderformen Von Keratosis palmoplantaris, Vaeine regelmaessig — dominante Form mit systematisierten lipomem, ferner zwei eifachrezessive, mit schwachsinn und Z.T. mit Hornhautveraenderungen des Auges (Ekdermalsyndrome), Derm, 94, pp. 286-308, (1947)
  • [5] Franceschetti A.T., Schynder U.W., Flegenhauer W.R., Die Cornea beim Richner-Hanhart syndrome. Ber 71, Zusammenkunft dt deutschen ophthalmologischen Gesellschaft, Heidelberg 1971, pp. 109-114, (1972)
  • [6] Goldsmith L.A., Molecular biology and molecular pathology of a newly described molecular disease. Tyrosinemia 11, Exp Cell Biol, 46, pp. 96-113, (1978)
  • [7] Balato N., Cusano F., Lembo G., Santoianni P., Tyrosinemia Type 11 in two cases previously reported as Richner-Hanhart syndrome, Derm, 173, pp. 66-74, (1986)
  • [8] Paige D.G., Claykin D., Bowron A., Harper J.I., Richner-Hanhart syndroms (oculocutaneous tyrosinemia tyrosinemia type II), J R Soc Med, 85, pp. 759-760, (1992)
  • [9] Fellman J.H., Vanbellinghen R.J., Jones R.T., Koler R.D., Soluble and mitochondrial forms of tyrosine aminotransferase. Relationship to human tyrosinemia, Biochemistry, 8, pp. 615-622, (1969)
  • [10] Faull K.F., Gan I., Halpern B., Metabolic studies in two patients with non hepatic tyrosinemia using deuterated tyrosine loads, Pediatr Res, 11, pp. 631-637, (1977)